Veritable’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-31,930
| Closed | -$7.09M | – | 40 |
|
|
2023
Q2 | $7.09M | Sell |
31,930
-659
| -2% | -$153K | 0.11% | 95 |
|
|
2023
Q1 | $7.88M | Sell |
32,589
-1,384
| -4% | -$340K | 0.13% | 81 |
|
|
2022
Q4 | $8.92M | Buy |
33,973
+55
| +0.2% | +$14.7K | 0.15% | 75 |
|
|
2022
Q3 | $7.64M | Sell |
33,918
-2,148
| -6% | -$521K | 0.15% | 79 |
|
|
2022
Q2 | $8.78M | Buy |
36,066
+1,381
| +4% | +$338K | 0.16% | 77 |
|
|
2022
Q1 | $8.39M | Buy |
34,685
+4,333
| +14% | +$996K | 0.13% | 85 |
|
|
2021
Q4 | $6.83M | Sell |
30,352
-2,412
| -7% | -$509K | 0.1% | 107 |
|
|
2021
Q3 | $6.97M | Buy |
32,764
+3,936
| +14% | +$906K | 0.11% | 100 |
|
|
2021
Q2 | $7.03M | Buy |
28,828
+5,417
| +23% | +$1.33M | 0.11% | 94 |
|
|
2021
Q1 | $5.83M | Buy |
23,411
+1,480
| +7% | +$353K | 0.1% | 105 |
|
|
2020
Q4 | $5.04M | Sell |
21,931
-1,554
| -7% | -$358K | 0.09% | 116 |
|
|
2020
Q3 | $5.97M | Sell |
23,485
-416
| -2% | -$103K | 0.12% | 93 |
|
|
2020
Q2 | $5.64M | Sell |
23,901
-853
| -3% | -$195K | 0.12% | 92 |
|
|
2020
Q1 | $5.02M | Sell |
24,754
-471
| -2% | -$103K | 0.12% | 96 |
|
|
2019
Q4 | $6.08M | Buy |
25,225
+503
| +2% | +$111K | 0.11% | 109 |
|
|
2019
Q3 | $4.78M | Buy |
24,722
+436
| +2% | +$83.7K | 0.09% | 124 |
|
|
2019
Q2 | $4.47M | Buy |
24,286
+242
| +1% | +$43.3K | 0.09% | 130 |
|
|
2019
Q1 | $4.57M | Sell |
24,044
-239
| -1% | -$45.6K | 0.09% | 127 |
|
|
2018
Q4 | $4.73M | Sell |
24,283
-469
| -2% | -$91.5K | 0.11% | 116 |
|
|
2018
Q3 | $5.13M | Buy |
24,752
+507
| +2% | +$99.9K | 0.1% | 117 |
|
|
2018
Q2 | $4.47M | Buy |
24,245
+157
| +0.7% | +$27.8K | 0.09% | 123 |
|
|
2018
Q1 | $4.11M | Buy |
24,088
+99
| +0.4% | +$18.2K | 0.09% | 125 |
|
|
2017
Q4 | $4.17M | Sell |
23,989
-3,006
| -11% | -$532K | 0.08% | 125 |
|
|
2017
Q3 | $5.03M | Sell |
26,995
-2,527
| -9% | -$448K | 0.11% | 119 |
|
|
2017
Q2 | $5.08M | Buy |
29,522
+3,508
| +13% | +$571K | 0.12% | 113 |
|
|
2017
Q1 | $4.27M | Sell |
26,014
-103
| -0.4% | -$17.1K | 0.1% | 119 |
|
|
2016
Q4 | $3.82M | Buy |
26,117
+520
| +2% | +$78.3K | 0.09% | 127 |
|
|
2016
Q3 | $4.27M | Buy |
25,597
+992
| +4% | +$168K | 0.11% | 118 |
|
|
2016
Q2 | $3.74M | Sell |
24,605
-1,376
| -5% | -$214K | 0.1% | 126 |
|
|
2016
Q1 | $3.9M | Buy |
25,981
+144
| +0.6% | +$21.4K | 0.1% | 123 |
|
|
2015
Q4 | $4.19M | Buy |
25,837
+618
| +2% | +$97.1K | 0.11% | 123 |
|
|
2015
Q3 | $3.49M | Buy |
25,219
+921
| +4% | +$145K | 0.1% | 133 |
|
|
2015
Q2 | $3.73M | Sell |
24,298
-8,262
| -25% | -$1.32M | 0.1% | 133 |
|
|
2015
Q1 | $5.21M | Sell |
32,560
-1,125
| -3% | -$177K | 0.11% | 144 |
|
|
2014
Q4 | $5.37M | Buy |
33,685
+1,007
| +3% | +$157K | 0.11% | 147 |
|
|
2014
Q3 | $4.59M | Sell |
32,678
-468
| -1% | -$61.1K | 0.1% | 155 |
|
|
2014
Q2 | $3.92M | Sell |
33,146
-1,230
| -4% | -$142K | 0.08% | 167 |
|
|
2014
Q1 | $4.24M | Buy |
34,376
+2,924
| +9% | +$355K | 0.09% | 155 |
|
|
2013
Q4 | $3.59M | Buy |
31,452
+1,532
| +5% | +$174K | 0.08% | 170 |
|
|
2013
Q3 | $3.35M | Buy |
29,920
+408
| +1% | +$44.2K | 0.08% | 170 |
|
|
2013
Q2 | $2.91M | Buy |
+29,512
| New | +$3.06M | 0.07% | 188 |
|
Other funds holding AMGN
Veritable's AMGN Position: Q3 2023 in Review
Veritable sold out of Amgen (AMGN) in Q3 2023, closing a stake of 31,930 shares — an estimated $7.09M sold.
Veritable first reported a position in AMGN in Q2 2013 and held it in 41 quarters. The position peaked at $8.92M in Q4 2022. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q3 2023.
- Veritable reported no remaining Amgen position as of Q3 2023 after selling out during the quarter.
- Veritable sold 31,930 Amgen shares in Q3 2023, an estimated $7.09M.
- Veritable first reported a position in Amgen in Q2 2013 and held it in 41 quarters.
- Veritable's Amgen position peaked at $8.92M in Q4 2022.
- 2,501 funds tracked by Wall St. Rank held Amgen as of Q3 2023.
Based on Veritable's 13F filing for Q3 2023.